HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Whole Foods ‘Hypoallergenic’ Litigation To Test ‘Sensitizer’ Definition, Consumer Perceptions

This article was originally published in The Rose Sheet

Executive Summary

A California federal judge has granted Whole Foods Market, Inc.’s motion to dismiss itself, all but one affiliate, and a number of plaintiff claims in the putative class action, but the core issue of contention – whether Whole Foods-branded “hypoallergenic” offerings are falsely labeled – remains to be litigated.

You may also be interested in...

Plaintiff Digs Deep In Almay Archives For ‘Hypoallergic’ Fraud Evidence

In the absence of FDA regulations, federal courts generally are weighing hypoallergenic false-advertising arguments against the “reasonable consumer” standard, with varying results. However, Almay may have provided a more substantive basis for assessing the truthfulness of its hypoallergenic claims via a letter to FDA on the subject – albeit one from 1973.

J&J Scores Early In ‘Hypoallergenic’ Case; Plaintiff’s Definition ‘Implausible,’ Court Says

A California federal judge is more receptive to J&J’s interpretation of “hypoallergenic” – as a term denoting reduced allergy risk compared with other products – than plaintiffs’ ingredient-based definition. Her ruling on the firm’s motion to dismiss differs sharply from a decision earlier this month in the same district concerning Whole Foods hypoallergenic claims, only adding to legal uncertainty.

Pollution Protection, Blue Light Defense Among Cosmetic Tests In High Demand

Craig Weiss, president of Consumer Product Testing Company, discussed trending cosmetics claims and testing that can be used to support them, as well as “claims that perhaps should not be made,” at ICMAD’s regulatory workshop in May.

Related Content





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts